Molecular Cytogenetics Market, By Product Type (Instruments, Consumables, Software and Services), By Technology (FISH, aCGH), By Application (Genetic Disorder, Cancer, Personalized Medicine, Others.), By Region (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Apr 2023

Code : CMI2491

Pages :145

Formats :

Excel and PDF

Industry : Biotechnology

Market Challenges And Opportunities

Global Molecular Cytogenetics Market – Driver

Launch of new products by key market players to expand product portfolio

To meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research, key market players are focused on launching new products to expand their product portfolio. For instance, in March 2020, Agilent Technologies Inc., provider of instruments, software, services, etc., launched three new microarrays to meet the needs of cytogenetic laboratories conducting both prenatal and postnatal research.

Molecular Cytogenetics Market Report Coverage

Restraints & Challenges:

Unfavorable reimbursement policies

Global Molecular Cytogenetics Market: Restraint

Unfavorable reimbursement policies

Unfavorable reimbursement policies represent a major restraint on the growth of the global molecular cytogenetics market. Insurance companies are refraining from reimbursing molecular diagnostic tests.

Moreover, the high cost of genetic testing is also expected to limit market growth. The cost of these tests typically ranges from US$ 300 to US$ 3,000 per test and are considered the most important technologies for early detection.

Global Molecular Cytogenetics Market Cross Sectional Analysis:

Rising incidence of cancer and genetic disorders in emerging economies is also expected to boost demand for molecular cytogenetic technologies in these regions. For instance, according to the World Health Organization, the number of new cancer cases diagnosed per year in Africa is expected to grow from over 1 million in 2019 to over 2.1 million in 2040.